Evidence Based Medicine on FHIR Implementation Guide
2.0.0-ballot - ballot
Evidence Based Medicine on FHIR Implementation Guide
2.0.0-ballot - ballot
Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 2.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
| Active as of 2022-01-10 |
<Citation xmlns="http://hl7.org/fhir">
<id value="58"/>
<meta>
<versionId value="25"/>
<lastUpdated value="2024-11-16T19:17:38.652Z"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: Citation 58</b></p><a name="58"> </a><a name="hc58"> </a><a name="58-en-US"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">version: 25; Last updated: 2024-11-16 19:17:38+0000</p></div><p><b>url</b>: <a href="Citation-58.html">Citation Citation for FEvIR Evidence 55: 14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY)</a></p><p><b>identifier</b>: FEvIR Object Identifier/https://fevir.net/FOI/58, <a href="http://terminology.hl7.org/6.1.0/NamingSystem-uri.html" title="As defined by RFC 3986 (http://www.ietf.org/rfc/rfc3986.txt)(with many schemes defined in many RFCs). For OIDs and UUIDs, use the URN form (urn:oid:(note: lowercase) and urn:uuid:). See http://www.ietf.org/rfc/rfc3001.txt and http://www.ietf.org/rfc/rfc4122.txt
This oid is used as an identifier II.root to indicate the the extension is an absolute URI (technically, an IRI). Typically, this is used for OIDs and GUIDs. Note that when this OID is used with OIDs and GUIDs, the II.extension should start with urn:oid or urn:uuid:
Note that this OID is created to aid with interconversion between CDA and FHIR - FHIR uses urn:ietf:rfc:3986 as equivalent to this OID. URIs as identifiers appear more commonly in FHIR.
This OID may also be used in CD.codeSystem.">Uniform Resource Identifier (URI)</a>/urn:oid:2.16.840.1.113883.4.642.40.44.15.20</p><p><b>version</b>: 2.0.0-ballot</p><p><b>title</b>: Citation for FEvIR Evidence 55: 14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY)</p><p><b>status</b>: Active</p><p><b>date</b>: 2022-01-10 13:29:15+0000</p><p><b>publisher</b>: HL7 International / Clinical Decision Support</p><p><b>contact</b>: HL7 International / Clinical Decision Support: <a href="http://www.hl7.org/Special/committees/dss">http://www.hl7.org/Special/committees/dss</a></p><p><b>description</b>: </p><div><p>This Citation Resource is referenced in an example for the EBMonFHIR Implementation Guide.</p>
</div><h3>UseContexts</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Code</b></td><td><b>Value[x]</b></td></tr><tr><td style="display: none">*</td><td><a href="http://hl7.org/fhir/R5/codesystem-citation-classification-type.html#citation-classification-type-fevir-platform-use">Citation Classification Type fevir-platform-use</a>: FEvIR Platform Use</td><td><span title="Codes:{http://hl7.org/fhir/citation-artifact-classifier fhir-resource}">FHIR Resource</span></td></tr></table><p><b>jurisdiction</b>: <span title="Codes:{http://unstats.un.org/unsd/methods/m49/m49.htm 001}">World</span></p><p><b>copyright</b>: </p><div><p>https://creativecommons.org/licenses/by-nc-sa/4.0/</p>
</div><p><b>author</b>: Brian S. Alper: </p><h3>Summaries</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Style</b></td><td><b>Text</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{http://hl7.org/fhir/citation-summary-style comppub}">Computable Publishing</span></td><td><div><p>14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY) [FHIR Resource], version 4. Contributors: Brian S. Alper, Joanne Dehnbostel, Khalid Shahin [Authors]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 55. Created December 17, 2020. Revised December 21, 2020. Accessed March 13, 2021. Available at: https://fevir.net/resources/Evidence/55. Computable resource at: https://fevir.net/resources/Evidence/55.</p>
</div></td></tr></table><h3>RelatedArtifacts</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Type</b></td><td><b>ResourceReference</b></td></tr><tr><td style="display: none">*</td><td>Derived From</td><td><a href="Evidence-55.html">14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY)</a></td></tr></table><blockquote><p><b>citedArtifact</b></p><p><b>identifier</b>: FEvIR Object Identifier/55</p><p><b>dateAccessed</b>: 2021-03-13</p><h3>Versions</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Value</b></td></tr><tr><td style="display: none">*</td><td>4</td></tr></table><h3>StatusDates</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Activity</b></td><td><b>Actual</b></td><td><b>Period</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{http://hl7.org/fhir/cited-artifact-status-type created}">Created</span></td><td>true</td><td>?? --> 2020-12-17</td></tr></table><h3>Titles</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Type</b></td><td><b>Language</b></td><td><b>Text</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{http://hl7.org/fhir/title-type primary}">Primary title</span></td><td><span title="Codes:{urn:ietf:bcp:47 en}">English</span></td><td><div><p>14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY).</p>
</div></td></tr></table><h3>Abstracts</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Type</b></td><td><b>Language</b></td><td><b>Text</b></td><td><b>Copyright</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{http://hl7.org/fhir/cited-artifact-abstract-type primary-human-use}">Primary human use</span></td><td><span title="Codes:{urn:ietf:bcp:47 en}">English</span></td><td><div><p>COVID-19 pneumonia remdesivir vs. placebo 14-day mortality (779 events among 6,744 participants, 3 randomized trials)\nRisk ratio 0.85 (95% CI 0.74 to 0.96) in fixed-effect analysis\nRisk ratio 0.81 (95% CI 0.60 to 1.08) in random-effects analysis</p>
</div></td><td><div><p>https://creativecommons.org/licenses/by-nc-sa/4.0/</p>
</div></td></tr></table><blockquote><p><b>publicationForm</b></p><h3>PublishedIns</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Type</b></td><td><b>Title</b></td><td><b>Publisher</b></td><td><b>PublisherLocation</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{http://hl7.org/fhir/published-in-type D019991}">Database</span></td><td>Fast Evidence Interoperability Resources (FEvIR) Platform</td><td>Computable Publishing LLC</td><td>Ipswich, MA, USA</td></tr></table><p><b>lastRevisionDate</b>: 2020-12-21</p><p><b>language</b>: <span title="Codes:{urn:ietf:bcp:47 en}">English</span></p><p><b>copyright</b>: </p><div><p>https://creativecommons.org/licenses/by-nc-sa/4.0/</p>
</div></blockquote><blockquote><p><b>webLocation</b></p><p><b>classifier</b>: <span title="Codes:{http://hl7.org/fhir/artifact-url-classifier json}">JSON</span>, <span title="Codes:{http://hl7.org/fhir/artifact-url-classifier computable-resource}">Computable resource</span></p><p><b>url</b>: <a href="https://fevir.net/resources/Evidence/55">https://fevir.net/resources/Evidence/55</a></p></blockquote><blockquote><p><b>classification</b></p><p><b>type</b>: <span title="Codes:{http://hl7.org/fhir/cited-artifact-classification-type knowledge-artifact-type}">Knowledge Artifact Type</span></p><p><b>classifier</b>: <span title="Codes:{http://hl7.org/fhir/citation-artifact-classifier fhir-resource}">FHIR Resource</span></p></blockquote><blockquote><p><b>classification</b></p><p><b>type</b>: <span title="Codes:">fhir-resource</span></p><p><b>classifier</b>: <span title="Codes:{http://hl7.org/fhir/fhir-types Evidence}">Evidence</span></p></blockquote><blockquote><p><b>classification</b></p><p><b>type</b>: <span title="Codes:">defined-in-text</span></p><p><b>classifier</b>: <span title="Codes:{https://fevir.net/resources/CodeSystem/179423 defined-in-text}">remdesivir</span>, <span title="Codes:{https://fevir.net/resources/CodeSystem/179423 defined-in-text}">COVID-19</span>, <span title="Codes:{https://fevir.net/resources/CodeSystem/179423 defined-in-text}">pharmaceutical treatment</span></p></blockquote><blockquote><p><b>contributorship</b></p><p><b>complete</b>: true</p><blockquote><p><b>entry</b></p><p><b>contributor</b>: <a href="#hc58/contributor0">Practitioner Brian S. Alper </a></p><p><b>forenameInitials</b>: BS</p><p><b>affiliation</b>: Computable Publishing LLC</p><p><b>contributionType</b>: <span title="Codes:{http://hl7.org/fhir/artifact-contribution-type conceptualization}">Conceptualization</span>, <span title="Codes:{http://hl7.org/fhir/artifact-contribution-type data-curation}">Data curation</span>, <span title="Codes:{http://hl7.org/fhir/artifact-contribution-type supervision}">Supervision</span></p><p><b>role</b>: <span title="Codes:{http://hl7.org/fhir/contributor-role author}">Author/Creator</span></p><p><b>correspondingContact</b>: true</p></blockquote><blockquote><p><b>entry</b></p><p><b>contributor</b>: <a href="#hc58/contributor1">Practitioner Joanne Dehnbostel </a></p><p><b>forenameInitials</b>: J</p><p><b>affiliation</b>: Computable Publishing LLC</p><p><b>contributionType</b>: <span title="Codes:{http://hl7.org/fhir/artifact-contribution-type formal-analysis}">Formal analysis</span>, <span title="Codes:{http://hl7.org/fhir/artifact-contribution-type data-curation}">Data curation</span></p><p><b>role</b>: <span title="Codes:{http://hl7.org/fhir/contributor-role author}">Author/Creator</span></p><p><b>correspondingContact</b>: false</p></blockquote><blockquote><p><b>entry</b></p><p><b>contributor</b>: <a href="#hc58/contributor2">Practitioner Khalid Shahin </a></p><p><b>forenameInitials</b>: K</p><p><b>affiliation</b>: Computable Publishing LLC</p><p><b>contributionType</b>: <span title="Codes:{http://hl7.org/fhir/artifact-contribution-type software}">Software</span></p><p><b>role</b>: <span title="Codes:{http://hl7.org/fhir/contributor-role author}">Author/Creator</span></p><p><b>correspondingContact</b>: false</p></blockquote></blockquote></blockquote><hr/><blockquote><p class="res-header-id"><b>Generated Narrative: Practitioner #contributor0</b></p><a name="58/contributor0"> </a><a name="hc58/contributor0"> </a><a name="58/contributor0-en-US"> </a><p><b>identifier</b>: <code>https://orcid.org/</code>/0000-0003-4300-4928</p><p><b>name</b>: Brian S. Alper </p><p><b>telecom</b>: <a href="mailto:balper@computablepublishing.com">balper@computablepublishing.com</a></p></blockquote><hr/><blockquote><p class="res-header-id"><b>Generated Narrative: Practitioner #contributor1</b></p><a name="58/contributor1"> </a><a name="hc58/contributor1"> </a><a name="58/contributor1-en-US"> </a><p><b>name</b>: Joanne Dehnbostel </p><p><b>telecom</b>: <a href="mailto:jdehnbostel@computablepublishing.com">jdehnbostel@computablepublishing.com</a></p></blockquote><hr/><blockquote><p class="res-header-id"><b>Generated Narrative: Practitioner #contributor2</b></p><a name="58/contributor2"> </a><a name="hc58/contributor2"> </a><a name="58/contributor2-en-US"> </a><p><b>name</b>: Khalid Shahin </p><p><b>telecom</b>: <a href="mailto:kshahin@computablepublishing.com">kshahin@computablepublishing.com</a></p></blockquote></div>
</text>
<contained>
<Practitioner>
<id value="contributor0"/>
<identifier>
<system value="https://orcid.org/"/>
<value value="0000-0003-4300-4928"/>
<assigner>
<display value="ORCID"/>
</assigner>
</identifier>
<name>
<family value="Alper"/>
<given value="Brian S."/>
</name>
<telecom>
<system value="email"/>
<value value="balper@computablepublishing.com"/>
</telecom>
</Practitioner>
</contained>
<contained>
<Practitioner>
<id value="contributor1"/>
<name>
<family value="Dehnbostel"/>
<given value="Joanne"/>
</name>
<telecom>
<system value="email"/>
<value value="jdehnbostel@computablepublishing.com"/>
</telecom>
</Practitioner>
</contained>
<contained>
<Practitioner>
<id value="contributor2"/>
<name>
<family value="Shahin"/>
<given value="Khalid"/>
</name>
<telecom>
<system value="email"/>
<value value="kshahin@computablepublishing.com"/>
</telecom>
</Practitioner>
</contained>
<url value="https://fevir.net/resources/Citation/58"/>
<identifier>
<type>
<coding>
<system value="http://terminology.hl7.org/CodeSystem/v2-0203"/>
<code value="ACSN"/>
<display value="Accession ID"/>
</coding>
<text value="FEvIR Object Identifier"/>
</type>
<system value="urn:ietf:rfc:3986"/>
<value value="https://fevir.net/FOI/58"/>
<assigner>
<display value="Computable Publishing LLC"/>
</assigner>
</identifier>
<identifier>
<system value="urn:ietf:rfc:3986"/>
<value value="urn:oid:2.16.840.1.113883.4.642.40.44.15.20"/>
</identifier>
<version value="2.0.0-ballot"/>
<title
value="Citation for FEvIR Evidence 55: 14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY)"/>
<status value="active"/>
<date value="2022-01-10T13:29:15.764Z"/>
<publisher value="HL7 International / Clinical Decision Support"/>
<contact>
<name value="HL7 International / Clinical Decision Support"/>
<telecom>
<system value="url"/>
<value value="http://www.hl7.org/Special/committees/dss"/>
</telecom>
</contact>
<description
value="This Citation Resource is referenced in an example for the EBMonFHIR Implementation Guide."/>
<useContext>
<code>
<system value="http://hl7.org/fhir/citation-classification-type"/>
<code value="fevir-platform-use"/>
<display value="FEvIR Platform Use"/>
</code>
<valueCodeableConcept>
<coding>
<system value="http://hl7.org/fhir/citation-artifact-classifier"/>
<code value="fhir-resource"/>
<display value="FHIR Resource"/>
</coding>
</valueCodeableConcept>
</useContext>
<jurisdiction>
<coding>
<system value="http://unstats.un.org/unsd/methods/m49/m49.htm"/>
<code value="001"/>
<display value="World"/>
</coding>
</jurisdiction>
<copyright value="https://creativecommons.org/licenses/by-nc-sa/4.0/"/>
<author>
<name value="Brian S. Alper"/>
</author>
<summary>
<style>
<coding>
<system value="http://hl7.org/fhir/citation-summary-style"/>
<code value="comppub"/>
<display value="Computable Publishing"/>
</coding>
</style>
<text
value="14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY) [FHIR Resource], version 4. Contributors: Brian S. Alper, Joanne Dehnbostel, Khalid Shahin [Authors]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 55. Created December 17, 2020. Revised December 21, 2020. Accessed March 13, 2021. Available at: https://fevir.net/resources/Evidence/55. Computable resource at: https://fevir.net/resources/Evidence/55."/>
</summary>
<relatedArtifact>
<type value="derived-from"/>
<resourceReference>🔗
<reference value="Evidence/55"/>
<type value="Evidence"/>
<display
value="14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY)"/>
</resourceReference>
</relatedArtifact>
<citedArtifact>
<identifier>
<type>
<coding>
<system value="http://terminology.hl7.org/CodeSystem/v2-0203"/>
<code value="ACSN"/>
<display value="Accession ID"/>
</coding>
<text value="FEvIR Object Identifier"/>
</type>
<system value="https://fevir.net"/>
<value value="55"/>
<assigner>
<display value="Computable Publishing LLC"/>
</assigner>
</identifier>
<dateAccessed value="2021-03-13"/>
<version>
<value value="4"/>
</version>
<statusDate>
<activity>
<coding>
<system value="http://hl7.org/fhir/cited-artifact-status-type"/>
<code value="created"/>
<display value="Created"/>
</coding>
</activity>
<actual value="true"/>
<period>
<end value="2020-12-17"/>
</period>
</statusDate>
<title>
<type>
<coding>
<system value="http://hl7.org/fhir/title-type"/>
<code value="primary"/>
<display value="Primary title"/>
</coding>
</type>
<language>
<coding>
<system value="urn:ietf:bcp:47"/>
<version value="4.0.1"/>
<code value="en"/>
<display value="English"/>
</coding>
</language>
<text
value="14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY)."/>
</title>
<abstract>
<type>
<coding>
<system value="http://hl7.org/fhir/cited-artifact-abstract-type"/>
<code value="primary-human-use"/>
<display value="Primary human use"/>
</coding>
</type>
<language>
<coding>
<system value="urn:ietf:bcp:47"/>
<code value="en"/>
<display value="English"/>
</coding>
</language>
<text
value="COVID-19 pneumonia remdesivir vs. placebo 14-day mortality (779 events among 6,744 participants, 3 randomized trials)\nRisk ratio 0.85 (95% CI 0.74 to 0.96) in fixed-effect analysis\nRisk ratio 0.81 (95% CI 0.60 to 1.08) in random-effects analysis"/>
<copyright value="https://creativecommons.org/licenses/by-nc-sa/4.0/"/>
</abstract>
<publicationForm>
<publishedIn>
<type>
<coding>
<system value="http://hl7.org/fhir/published-in-type"/>
<code value="D019991"/>
<display value="Database"/>
</coding>
</type>
<title
value="Fast Evidence Interoperability Resources (FEvIR) Platform"/>
<publisher>
<type value="Organization"/>
<display value="Computable Publishing LLC"/>
</publisher>
<publisherLocation value="Ipswich, MA, USA"/>
</publishedIn>
<lastRevisionDate value="2020-12-21"/>
<language>
<coding>
<system value="urn:ietf:bcp:47"/>
<version value="4.0.1"/>
<code value="en"/>
<display value="English"/>
</coding>
</language>
<copyright value="https://creativecommons.org/licenses/by-nc-sa/4.0/"/>
</publicationForm>
<webLocation>
<classifier>
<coding>
<system value="http://hl7.org/fhir/artifact-url-classifier"/>
<code value="json"/>
<display value="JSON"/>
</coding>
</classifier>
<classifier>
<coding>
<system value="http://hl7.org/fhir/artifact-url-classifier"/>
<code value="computable-resource"/>
<display value="Computable resource"/>
</coding>
</classifier>
<url value="https://fevir.net/resources/Evidence/55"/>
</webLocation>
<classification>
<type>
<coding>
<system
value="http://hl7.org/fhir/cited-artifact-classification-type"/>
<code value="knowledge-artifact-type"/>
<display value="Knowledge Artifact Type"/>
</coding>
</type>
<classifier>
<coding>
<system value="http://hl7.org/fhir/citation-artifact-classifier"/>
<code value="fhir-resource"/>
<display value="FHIR Resource"/>
</coding>
</classifier>
</classification>
<classification>
<type>
<text value="fhir-resource"/>
</type>
<classifier>
<coding>
<system value="http://hl7.org/fhir/fhir-types"/>
<code value="Evidence"/>
<display value="Evidence"/>
</coding>
</classifier>
</classification>
<classification>
<type>
<text value="defined-in-text"/>
</type>
<classifier>
<coding>
<system value="https://fevir.net/resources/CodeSystem/179423"/>
<code value="defined-in-text"/>
<display value="Defined in text"/>
</coding>
<text value="remdesivir"/>
</classifier>
<classifier>
<coding>
<system value="https://fevir.net/resources/CodeSystem/179423"/>
<code value="defined-in-text"/>
<display value="Defined in text"/>
</coding>
<text value="COVID-19"/>
</classifier>
<classifier>
<coding>
<system value="https://fevir.net/resources/CodeSystem/179423"/>
<code value="defined-in-text"/>
<display value="Defined in text"/>
</coding>
<text value="pharmaceutical treatment"/>
</classifier>
</classification>
<contributorship>
<complete value="true"/>
<entry>
<contributor>
<reference value="#contributor0"/>
<type value="Practitioner"/>
</contributor>
<forenameInitials value="BS"/>
<affiliation>
<display value="Computable Publishing LLC"/>
</affiliation>
<contributionType>
<coding>
<system value="http://hl7.org/fhir/artifact-contribution-type"/>
<code value="conceptualization"/>
<display value="Conceptualization"/>
</coding>
</contributionType>
<contributionType>
<coding>
<system value="http://hl7.org/fhir/artifact-contribution-type"/>
<code value="data-curation"/>
<display value="Data curation"/>
</coding>
</contributionType>
<contributionType>
<coding>
<system value="http://hl7.org/fhir/artifact-contribution-type"/>
<code value="supervision"/>
<display value="Supervision"/>
</coding>
</contributionType>
<role>
<coding>
<system value="http://hl7.org/fhir/contributor-role"/>
<code value="author"/>
<display value="Author/Creator"/>
</coding>
</role>
<correspondingContact value="true"/>
</entry>
<entry>
<contributor>
<reference value="#contributor1"/>
<type value="Practitioner"/>
</contributor>
<forenameInitials value="J"/>
<affiliation>
<display value="Computable Publishing LLC"/>
</affiliation>
<contributionType>
<coding>
<system value="http://hl7.org/fhir/artifact-contribution-type"/>
<code value="formal-analysis"/>
<display value="Formal analysis"/>
</coding>
</contributionType>
<contributionType>
<coding>
<system value="http://hl7.org/fhir/artifact-contribution-type"/>
<code value="data-curation"/>
<display value="Data curation"/>
</coding>
</contributionType>
<role>
<coding>
<system value="http://hl7.org/fhir/contributor-role"/>
<code value="author"/>
<display value="Author/Creator"/>
</coding>
</role>
<correspondingContact value="false"/>
</entry>
<entry>
<contributor>
<reference value="#contributor2"/>
<type value="Practitioner"/>
</contributor>
<forenameInitials value="K"/>
<affiliation>
<display value="Computable Publishing LLC"/>
</affiliation>
<contributionType>
<coding>
<system value="http://hl7.org/fhir/artifact-contribution-type"/>
<code value="software"/>
<display value="Software"/>
</coding>
</contributionType>
<role>
<coding>
<system value="http://hl7.org/fhir/contributor-role"/>
<code value="author"/>
<display value="Author/Creator"/>
</coding>
</role>
<correspondingContact value="false"/>
</entry>
</contributorship>
</citedArtifact>
</Citation>
IG © 2024+ HL7 International / Clinical Decision Support. Package hl7.fhir.uv.ebm#2.0.0-ballot based on FHIR 6.0.0-ballot2. Generated 2024-11-21
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change